Subsequently, the MET oncogene, a tyrosine kinase hepatocyte growth factor (HGF) receptor, was explored in a preclinical (murine model) study, which demonstrated an association between high MET expression levels and oral cancer development [81]. The gene discussed is MET; the disease is lip and oral cavity carcinoma.